Public Employees Retirement System of Ohio Increases Stock Position in Bruker Corporation $BRKR

Key Points

• The Public Employees Retirement System of Ohio increased its holding in Bruker Corporation by 60.8%, acquiring an additional 21,043 shares, bringing its total to 55,672 shares valued at $2,294,000.
• Bruker reported earnings of $0.32 per share for the last quarter, missing analysts' estimates, and its revenue fell 0.4% year-over-year, totaling $797.40 million.
• The company recently declared a quarterly dividend of $0.05 per share, with the ex-dividend date set for September 23rd, reflecting an annualized yield of 0.6%.

Public Employees Retirement System of Ohio increased its position in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) by 60.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 55,672 shares of the medical research company's stock after buying an additional 21,043 shares during the period. Public Employees Retirement System of Ohio's holdings in Bruker were worth $2,294,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in BRKR. Sculptor Capital LP lifted its holdings in Bruker by 51.6% during the first quarter. Sculptor Capital LP now owns 2,598,438 shares of the medical research company's stock valued at $108,459,000 after purchasing an additional 884,423 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in Bruker by 107.3% during the first quarter. Goldman Sachs Group Inc. now owns 1,465,319 shares of the medical research company's stock valued at $61,162,000 after purchasing an additional 758,301 shares in the last quarter. AQR Capital Management LLC lifted its holdings in Bruker by 65.9% during the first quarter. AQR Capital Management LLC now owns 1,476,605 shares of the medical research company's stock valued at $60,688,000 after purchasing an additional 586,516 shares in the last quarter. Nuveen LLC purchased a new position in Bruker during the first quarter valued at $20,764,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Bruker during the first quarter valued at $19,369,000. 79.52% of the stock is owned by hedge funds and other institutional investors.

Bruker Price Performance

Shares of BRKR opened at $34.83 on Friday. Bruker Corporation has a 1-year low of $28.53 and a 1-year high of $67.42. The stock has a market cap of $5.28 billion, a PE ratio of 66.98, a P/E/G ratio of 4.83 and a beta of 1.20. The firm has a 50-day simple moving average of $33.61 and a two-hundred day simple moving average of $37.59. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.61 and a quick ratio of 0.70.

Bruker (NASDAQ:BRKR - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The medical research company reported $0.32 earnings per share for the quarter, missing analysts' consensus estimates of $0.33 by ($0.01). Bruker had a net margin of 2.31% and a return on equity of 17.89%. The company had revenue of $797.40 million for the quarter, compared to analyst estimates of $811.17 million. During the same quarter in the prior year, the business earned $0.52 earnings per share. Bruker's revenue was down .4% on a year-over-year basis. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. As a group, analysts forecast that Bruker Corporation will post 2.69 EPS for the current year.

Bruker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 3rd. Shareholders of record on Tuesday, September 23rd will be given a dividend of $0.05 per share. The ex-dividend date is Tuesday, September 23rd. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.6%. Bruker's dividend payout ratio (DPR) is currently 38.46%.

Analysts Set New Price Targets

A number of brokerages have recently commented on BRKR. Barclays reduced their target price on shares of Bruker from $43.00 to $40.00 and set an "overweight" rating for the company in a research report on Thursday. Wells Fargo & Company reduced their target price on shares of Bruker from $60.00 to $50.00 and set an "overweight" rating for the company in a research report on Tuesday, August 5th. Jefferies Financial Group set a $60.00 target price on shares of Bruker and gave the company a "buy" rating in a research report on Monday, August 4th. Stifel Nicolaus set a $40.00 target price on shares of Bruker and gave the company a "hold" rating in a research report on Tuesday, August 5th. Finally, Bank of America reduced their target price on shares of Bruker from $61.00 to $50.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. Five equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $51.00.

Insider Buying and Selling at Bruker

In other Bruker news, Director Cynthia M. Friend sold 3,535 shares of Bruker stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $32.25, for a total transaction of $114,003.75. Following the completion of the sale, the director directly owned 18,016 shares in the company, valued at $581,016. This trade represents a 16.40% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 27.30% of the stock is currently owned by corporate insiders.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Corporation (NASDAQ:BRKR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.